Symbiosis Pharmaceutical Services has expanded its sterile biologics manufacturing facility in Scotland, UK by 25%.   The company has invested more than $1.9 million in the expansion of its Stirling site, doubling its current footprint with an additional 8,000 sq.-ft. of space to house administrative, management and operational teams, as well as the expansion of its manufacturing space and its supporting services infrastructure.    The new operational area also provides additional capacity f...